Trending in Health
British Women Rank Among Europe's Angriest, Survey Finds
Breakthrough Pancreatic Cancer Drug Shows Surprising Survival Gains
World-First AI-Designed Vaccine Passes Human Trial at Cambridge
AI-Designed ‘Universal Vaccine’ Could Future-Proof Humans Against Unknown Viruses
All Health Stories
-
Ancient Bacterium Found in 5,000-Year-Old Ice Resists Modern Antibiotics
A 5,000-year-old bacterium discovered in Romanian cave ice exhibits resistance to multiple modern antibiotics, raising concerns and offering potential for new drug discovery.
-
Your Home's "Comfort Room" Unveils Deep Attachment Needs, Psychology Reveals
Discover how the room you unconsciously gravitate towards in your home reveals your core attachment styles and unmet emotional needs, according to psychological insights.
-
Mental Health Crisis: Profit Over People?
An investigation into how societal issues are reframed as individual mental illness for profit, obscuring systemic causes.
-
7 Cognitive Traits of Those Who Silence Distractions for Memory Recall
Discover the distinct cognitive traits observed in individuals who instinctively reduce distractions, like turning down the TV, when trying to access memories. Learn about their metacognitive awareness and focus.
-
Dog Gut Microbes May Predict Cancer Treatment Success
New research suggests specific gut bacteria in dogs could predict their survival rates after cancer immunotherapy, offering potential for improved diagnostics and treatments.
-
Semaglutide Shows Promise in Reversing Osteoarthritis Damage
New research suggests semaglutide, known for diabetes and weight loss, may reverse joint tissue damage in osteoarthritis by reprogramming cell metabolism.
-
The Hidden Cost of Competence: Why High Achievers Resent Being Needed
Psychology reveals how early rewards for capability can create a deep-seated confusion between being needed and being loved, leading to quiet resentment in high performers.
-
New Pill Orforglipron Outperforms Ozempic in Key Diabetes and Weight Loss Trial
A groundbreaking Phase 3 trial reveals orforglipron, an oral GLP-1 drug, demonstrates superior efficacy in blood sugar control and weight reduction compared to oral semaglutide.